{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T08:51:00Z","timestamp":1768726260016,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyperandrogenemia and metabolic disturbances during postnatal life are strongly linked both to polycystic ovary syndrome and other conditions that arise from prenatal exposure to androgen excess. In an animal model of this condition, we reported that insulin sensitivity (IS) was lower in young female sheep born to testosterone-treated mothers versus sheep born to non-exposed mothers (control). This lower insulin sensitivity remains throughout reproductive life. However, it is unknown whether abnormal postnatal levels of testosterone (T) further decrease IS derived from prenatal exposure to testosterone. Therefore, we assessed the effects of an acute testosterone administration (40\u2009mg) on IS and insulin secretion during an intravenous glucose tolerance test performed at 40 weeks of age (adulthood) in previously ovariectomized sheep at 26 weeks of age (prepuberty), that were either prenatally exposed to testosterone (T-females, n\u2009=\u20096) or not (C-females, n\u2009=\u20096). The incremental area under the curve of insulin was greater in C-females both with or without the acute testosterone treatment (P\u2009&lt;\u20090.05). The ISI-Composite was lower after an acute testosterone treatment, only in T-females. We conclude that prenatal exposure to testosterone disrupts pancreatic insulin secretion in response to glucose and that in this setting further hyperandrogenemia may predispose to lower insulin sensitivity.<\/jats:p>","DOI":"10.1038\/s41598-019-57197-x","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T11:03:00Z","timestamp":1579086180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prenatal Testosterone Exposure Disrupts Insulin Secretion And\u00a0Promotes Insulin Resistance"],"prefix":"10.1038","volume":"10","author":[{"given":"Albert","family":"Carrasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica P.","family":"Recabarren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro P.","family":"Rojas-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Sir-Petermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio E.","family":"Recabarren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,15]]},"reference":[{"key":"57197_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/humupd\/dmi013","volume":"11","author":"DH Abbott","year":"2005","unstructured":"Abbott, D. H., Barnett, D. K., Bruns, C. M. & Dumesic, D. A. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum. Reprod. Update 11, 357\u2013374 (2005).","journal-title":"Hum. Reprod. Update"},{"key":"57197_CR2","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1210\/jc.2015-4009","volume":"101","author":"R Pasquali","year":"2016","unstructured":"Pasquali, R. et al. Defining hyperandrogenism in women with polycystic ovary syndrome: a challenging perspective. J. Clin. Endocrinol. Metab. 101, 2013\u20132022 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"57197_CR3","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"Yildiz, B. O., Bozdag, G., Yapici, Z., Esinler, I. & Yarali, H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum. Reprod. 27, 3067\u20133073 (2012).","journal-title":"Hum. Reprod."},{"key":"57197_CR4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0015-0282(99)00468-9","volume":"73","author":"KJ Mather","year":"2000","unstructured":"Mather, K. J., Kwan, F. & Corenblum, B. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil. Steril. 73, 150\u2013156 (2000).","journal-title":"Fertil. Steril."},{"key":"57197_CR5","first-page":"19","volume":"26","author":"G Wilcox","year":"2005","unstructured":"Wilcox, G. Insulin and insulin resistance. Clin. Biochem. Rev. 26, 19\u201339 (2005).","journal-title":"Clin. Biochem. Rev."},{"key":"57197_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jsbmb.2009.12.010","volume":"122","author":"CG Baptiste","year":"2010","unstructured":"Baptiste, C. G., Battista, M. C., Trottier, A. & Baillargeon, J. P. Insulin and hyperandrogenism in women with polycystic ovary syndrome. J. Steroid Biochem. Mol. Biol. 122, 42\u201352 (2010).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"57197_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3109\/09513590.2012.736563","volume":"29","author":"AD Nascimento","year":"2013","unstructured":"Nascimento, A. D., Silva-Lara, L. A., Japur de S\u00e1 Rosa-e-Silva, A. C., Ferriani, R. A. & Reis, R. M. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome. Gynecol. Endocrinol. 29, 246\u2013249 (2013).","journal-title":"Gynecol. Endocrinol."},{"key":"57197_CR8","first-page":"714","volume":"124","author":"L Liao","year":"2011","unstructured":"Liao, L. et al. Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome. Chin. Med. J. (Engl.) 124, 714\u2013718 (2011).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"57197_CR9","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.fertnstert.2012.07.1057","volume":"98","author":"E Lerchbaum","year":"2012","unstructured":"Lerchbaum, E., Schwetz, V., Giuliani, A., Pieber, T. R. & Obermayer-Pietsch, B. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome. Fertil. Steril. 98, 1318\u20131325 (2012).","journal-title":"Fertil. Steril."},{"key":"57197_CR10","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.2337\/diacare.28.7.1636","volume":"28","author":"N Pitteloud","year":"2005","unstructured":"Pitteloud, N. et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 28, 1636\u20131642 (2005).","journal-title":"Diabetes Care"},{"key":"57197_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1677\/joe.1.06357","volume":"187","author":"S Morimoto","year":"2005","unstructured":"Morimoto, S. et al. Protective effect of drug on early apoptotic damage induced by streptozotocin in rat pancreas. J. Endocrinol. 187, 217\u2013224 (2005).","journal-title":"J. Endocrinol."},{"key":"57197_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cmet.2016.03.015","volume":"23","author":"G Navarro","year":"2016","unstructured":"Navarro, G. et al. Extranuclear actions of the androgen receptor enhance glucose-stimulated insulin secretion in the male. Cell Metab. 23, 837\u2013851 (2016).","journal-title":"Cell Metab."},{"key":"57197_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrendo.2009.212","volume":"5","author":"M Zitzmann","year":"2009","unstructured":"Zitzmann, M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat. Rev. Endocrinol. 5, 673\u2013681 (2009).","journal-title":"Nat. Rev. Endocrinol."},{"key":"57197_CR14","first-page":"1206","volume":"85","author":"JR Eisner","year":"2000","unstructured":"Eisner, J. R., Dumesic, D. A., Kemnitz, J. W. & Abbott, D. H. Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J. Clin. Endocrinol. Metab. 85, 1206\u20131210 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"57197_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1152\/ajpendo.00107.2005","volume":"289","author":"SE Recabarren","year":"2005","unstructured":"Recabarren, S. E. et al. Postnatal consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. Am. J. Physiol. Endocrinol. Metab. 289, 801\u2013806 (2005).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"57197_CR16","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda, M. & DeFronzo, R. A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462\u20131470 (1999).","journal-title":"Diabetes Care"},{"key":"57197_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0168-8227(93)90079-K","volume":"20","author":"H Grulet","year":"1993","unstructured":"Grulet, H., Durlach, V., Hecart, A. C., Gross, A. & Leutenegger, M. Study of the rate of early glucose disappearance following insulin injection: insulin sensitivity index. Diabetes Res. Clin. Pract. 20, 201\u2013207 (1993).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"57197_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/bmb\/60.1.123","volume":"60","author":"AL Fowden","year":"2001","unstructured":"Fowden, A. L. & Hill, D. J. Intra-uterine programming of the endocrine pancreas. Br. Med. Bull. 60, 123\u2013142 (2001).","journal-title":"Br. Med. Bull."},{"key":"57197_CR19","doi-asserted-by":"publisher","first-page":"e56263","DOI":"10.1371\/journal.pone.0056263","volume":"8","author":"M Rae","year":"2013","unstructured":"Rae, M. et al. The pancreas is altered by in utero androgen exposure: implications for clinical conditions such as polycystic ovary syndrome (PCOS). PLoS ONE 8, e56263, https:\/\/doi.org\/10.1371\/journal.pone.0056263 (2013).","journal-title":"PLoS ONE"},{"key":"57197_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep27408","volume":"6","author":"S Ramaswamy","year":"2016","unstructured":"Ramaswamy, S. et al. Developmental programming of polycystic ovary syndrome (PCOS): prenatal androgens establish pancreatic islet \u03b1\/\u03b2 cell ratio and subsequent insulin secretion. Sci Rep. 6, 27408, https:\/\/doi.org\/10.1038\/srep27408 (2016).","journal-title":"Sci Rep."},{"key":"57197_CR21","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1093\/humrep\/17.10.2573","volume":"17","author":"T Sir-Petermann","year":"2002","unstructured":"Sir-Petermann, T. et al. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum. Reprod. 17, 2573\u20132579 (2002).","journal-title":"Hum. Reprod."},{"key":"57197_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/14767058.2017.1373085","volume":"32","author":"M Recabarren","year":"2019","unstructured":"Recabarren, M. et al. Long-term testosterone treatment during pregnancy does not alter insulin or glucose profile in a sheep model of polycystic ovary syndrome. J. Matern. Fetal Neonatal Med. 32, 173\u2013178 (2019).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"57197_CR23","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1093\/humrep\/deg482","volume":"18","author":"M Maliqueo","year":"2003","unstructured":"Maliqueo, M. et al. Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of \u03b2-cell dysfunction? Hum. Reprod. 18, 2683\u20132688 (2003).","journal-title":"Hum. Reprod."},{"key":"57197_CR24","unstructured":"Sandoval, D. et al. Impact of the hyperandrogenic intrauterine microenvironment on development and function of fetal beta cells in females. XXVII Annual Meeting of the Chilean Society for Reproduction and Development 2\u20135 September, Antofagasta, Chile (2016)."},{"key":"57197_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1113\/expphysiol.1984.sp002808","volume":"69","author":"AL Fowden","year":"1984","unstructured":"Fowden, A. L. & Comline, R. S. The effects of pancreatectomy on the sheep fetus in utero. Q. J. Exp. Physiol. 69, 319\u2013330 (1984).","journal-title":"Q. J. Exp. Physiol."},{"key":"57197_CR26","doi-asserted-by":"publisher","first-page":"e11302","DOI":"10.1371\/journal.pone.0011302","volume":"24","author":"S Liu","year":"2010","unstructured":"Liu, S. et al. Androgen excess produce systemic oxidative stress and predisposes to beta-cell failure in female mice. PLoS One 24, e11302, https:\/\/doi.org\/10.1371\/journal.pone.0011302 (2010).","journal-title":"PLoS One"},{"key":"57197_CR27","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1210\/jc.2004-0918","volume":"89","author":"C Bruns","year":"2004","unstructured":"Bruns, C. et al. Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys. J. Clin. Endocrinol. Metab. 89, 6218\u20136223 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"57197_CR28","first-page":"E555","volume":"259","author":"A Holm\u00e4ng","year":"1990","unstructured":"Holm\u00e4ng, A., Svedberg, J., Jennische, E. & Bj\u00f6rntorp, P. Effects of testosterone on muscle insulin sensitivity and morphology in female rats. Am. J. Physiol. 259, E555\u2013E560 (1990).","journal-title":"Am. J. Physiol."},{"key":"57197_CR29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1677\/joe.1.07070","volume":"192","author":"A Corbould","year":"2007","unstructured":"Corbould, A. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J. Endocrinol. 192, 585\u2013594 (2007).","journal-title":"J. Endocrinol."},{"key":"57197_CR30","first-page":"577","volume":"75","author":"TP Ciaraldi","year":"1992","unstructured":"Ciaraldi, T. P. et al. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. 75, 577\u2013583 (1992).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"57197_CR31","first-page":"E197","volume":"264","author":"D Rosenbaum","year":"1993","unstructured":"Rosenbaum, D., Haber, R. S. & Dunaif, A. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am. J. Physiol. 264, E197\u2013E202 (1993).","journal-title":"Am. J. Physiol."},{"key":"57197_CR32","first-page":"321","volume":"114","author":"A Ivandi\u0107","year":"2002","unstructured":"Ivandi\u0107, A. et al. Insulin resistance and androgens in healthy women with different body fat distributions. Wien. Klin. Wochenschr. 114, 321\u2013326 (2002).","journal-title":"Wien. Klin. Wochenschr."},{"key":"57197_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mce.2017.01.051","volume":"444","author":"N Crisosto","year":"2017","unstructured":"Crisosto, N. et al. Testosterone increases CCL-2 expression in visceral adipose tissue from obese women of reproductive age. Mol. Cell. Endocrinol. 444, 59\u201366 (2017).","journal-title":"Mol. Cell. Endocrinol."},{"issue":"113","key":"57197_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1095\/biolreprod.115.136283","volume":"94","author":"C Lu","year":"2016","unstructured":"Lu, C. et al. Developmental programming: prenatal testosterone excess and insulin signaling disruptions in female sheep. Biol. Reprod. 94(113), 1\u201311, https:\/\/doi.org\/10.1095\/biolreprod.115.136283 (2016).","journal-title":"Biol. Reprod."},{"key":"57197_CR35","doi-asserted-by":"publisher","first-page":"670.e1","DOI":"10.1016\/j.ajog.2008.01.037","volume":"198","author":"RP Kauffman","year":"2008","unstructured":"Kauffman, R. P., Baker, T. E., Baker, V. M., DiMarino, P. & Castracane, V. D. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria. Am. J. Obstet. Gynecol. 198, 670.e1\u2013670.e7 (2008).","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57197-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57197-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57197-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:42:14Z","timestamp":1670305334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57197-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["57197"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-57197-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,15]]},"assertion":[{"value":"25 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"404"}}